View : 691 Download: 0
Hybrid robotic single-site myomectomy using the gelpoint platform
- Title
- Hybrid robotic single-site myomectomy using the gelpoint platform
- Authors
- Yuk J.-S.; Kim Y.A.; Lee J.H.
- Ewha Authors
- 이정훈
- SCOPUS Author ID
- 이정훈
- Issue Date
- 2019
- Journal Title
- Journal of Laparoendoscopic and Advanced Surgical Techniques
- ISSN
- 1092-6429
- Citation
- Journal of Laparoendoscopic and Advanced Surgical Techniques vol. 29, no. 11, pp. 1475 - 1480
- Keywords
- gynecology; laparoscopy; myomectomy; robotic surgery; single-port surgery
- Publisher
- Mary Ann Liebert Inc.
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Background: To overcome the limitations of single-port laparoscopic myomectomy (SP-LM) and robotic single-site myomectomy (RSSM), we designed a new surgical technique, the so-called hybrid RSSM (H-RSSM), by integrating the advantages of both procedures. This study describes the surgical technique of H-RSSM and reports our initial experiences. Materials and Methods: Between February 2018 and September 2018, H-RSSM was performed in 25 women with symptomatic fibroids. During the H-RSSM, the enucleation of the fibroid was carried out using single-port laparoscopy and the uterine defect was repaired using robotic single-site surgery. To assess the feasibility and efficacy of H-RSSM, the results of this study were compared with those of our previous study on SP-LM and its modified surgical technique, so-called single-port laparoscopically assisted transumbilical ultraminilaparotomic myomectomy (SPLA-TUM). Results: The mean operation time, hemoglobin change, return of bowel activity, and length of hospital stay were 69.4 ± 18.2 minutes, 1.2 ± 0.9 g/dL, 37.1 ± 15.5 hours, and 4.0 ± 0.8 days, respectively. There was no conversion to laparotomy or multiport laparoscopy. There were no surgical or wound complications. Comparing with SP-LM and SPLA-TUM, H-RSSM had significantly shorter operation time and return of bowel activity. Conclusion: H-RSSM can reduce operating time and the conversion rate to multiport laparoscopy and can be considered a feasible alternative for selected patients with symptomatic fibroids. However, further studies are needed to clearly demonstrate these benefits. © Copyright 2019, Mary Ann Liebert, Inc., publishers 2019.
- DOI
- 10.1089/lap.2019.0313
- Appears in Collections:
- 의료원 > 의료원 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML